Enjoy Free Shipping on Orders above $220
10% off on orders over $120 up to $20 Use Code: MYVAL10
Megaplat 100 mg Injection is a specialized chemotherapy injection designed to address the complex challenges of Colorectal Cancer treatment. This advanced pharmaceutical intervention contains Oxaliplatin as its primary active ingredient, representing a critical breakthrough in oncological medical science. Alkem Laboratories Ltd manufactures it.
The medication belongs to the platinum-based antineoplastic agent class. It is specifically engineered to target and combat malignant cell proliferation with unprecedented precision.
Oxaliplatin operates through a sophisticated molecular mechanism that interferes with cancer cell DNA replication, creating intricate crosslinks that disrupt cellular division processes.
This targeted approach allows for more effective intervention in cancer progression, minimizing damage to healthy surrounding tissues. It simultaneously attacks cancerous cells. Healthcare professionals carefully administer the injection as part of comprehensive chemotherapy protocols, tailoring treatment to individual patient requirements and specific Cancer characteristics.
The medication's development reflects years of intensive medical research, offering oncologists a powerful tool in the battle against Colorectal Cancer. Megaplat represents a significant advancement in targeted Cancer treatment strategies by providing a mechanism that directly challenges cancer cell reproduction. It brings hope to patients facing this challenging medical condition.
Megaplat 100 mg Injection delivers comprehensive Cancer treatment benefits through its advanced pharmacological mechanism. The medication provides critical interventions in Cancer management by:
The medication's precision allows for more targeted therapeutic approaches, potentially improving patient outcomes and quality of life during Cancer treatment. By specifically interfering with Cancer cell reproduction mechanisms, Megaplat helps slow disease progression and supports overall treatment objectives.
Its ability to create DNA crosslinks interrupts crucial cellular processes, effectively compromising the survival and replication of malignant cells.
Megaplat 100 mg Injection is a prescription medication qualified healthcare professionals must administer. Here are the general guidelines:
The substitutes available for Megaplat injection are:
| $43.79 / Injection |
Megaplat 100 mg is a potent medical treatment with potential side effects. These may include:
These adverse effects typically require medical monitoring and may vary between patients.
Liver disease
Patients with liver conditions require careful assessment before Megaplat treatment. Dose modifications and frequent liver function monitoring are essential. Consult a doctor for safety.
Kidney impairment
Renal function must be evaluated before treatment. Based on kidney health status, potential dose adjustments may be necessary. Consult a doctor for safety.
Pregnant and breastfeeding women
Strict contraindications for pregnant women due to the possibility of fetal harm. Breastfeeding mothers should discontinue nursing during treatment due to potential genetic toxicity. Use only when prescribed and benefits outweigh risks. Approval by a medical expert is vital.
Avoid
Avoid alcohol consumption, immune-suppressing supplements, and high-stress environments during treatment.
Megaplat uses advanced molecular mechanisms to interrupt Cancer cell DNA, causing targeted cell destruction. The medication prevents Cancer cell division by creating precise DNA crosslinks, significantly reducing tumor growth and controlling the spread of malignant cells during treatment.
While primarily designed for Colorectal Cancer, oncologists may consider Oxaliplatin for other Cancer types after comprehensive medical evaluation. Individual patient characteristics, Cancer stage, and specific molecular profiles determine potential alternative treatment applications.
Oncologists meticulously determine dosage, considering multiple factors, including the patient's overall health, specific Cancer characteristics, treatment response, and individual physiological parameters. Precise administration occurs in carefully controlled medical environments.
Potential long-term effects include peripheral neuropathy, fatigue, and subtle changes in cellular function. Comprehensive medical monitoring, regular follow-ups, and individualized patient care help manage and mitigate potential ongoing treatment consequences.
Megaplat offers a more targeted approach with potentially fewer systemic side effects than traditional chemotherapy. Its precise molecular mechanism allows for more focused Cancer cell intervention, potentially reducing the overall treatment impact on the patient's healthy tissues.
